FLUQUADRI
Land: Indonesien
Sprog: indonesisk
Kilde: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
Produktets egenskaber
(SPC)
23-08-2019
Send anmodning.
Aktiv bestanddel:
A/BRISBANE/02/2018 (H1N1) PDM09 LIKE VIRUS, A/KANSAS/14/2017 (H3N2) LIKE VIRUS (A/KANSAS/14/2017, X-327), B/COLORADO/06/2017-LIKE VIRUS (B/MARYLAND/15/2016, BX-69A (VICTORIA LINEAGE)), B/PHUKET/3073/2013-LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)
Tilgængelig fra:
AVENTIS PHARMA - Indonesia
INN (International Name):
A/BRISBANE/02/2018 (H1N1) PDM09 LIKE VIRUS, A/KANSAS/14/2017 (H3N2) LIKE VIRUS (A/KANSAS/14/2017, X-327), B/COLORADO/06/2017-LIKE VIRUS (B/MARYLAND/15/2016, BX-69A (VICTORIA LINEAGE)), B/PHUKET/3073/2013-LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)
Dosering:
15 MCG /15 MCG /15 MCG /15 MCG
Lægemiddelform:
SUSPENSI INJEKSI
Enheder i pakken:
DUS, 5 SYRINGE @ 0,5 ML ( 1 DOSIS)
Fremstillet af:
SANOFI PASTEUR, INC - United States of America
Autorisation dato:
2021-06-19
Produktets egenskaber
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
Læs hele dokumentet
